Related Experiment Video
Updated: Nov 7, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Interventional treatment of acute myocardial infarction-related cardiogenic shock
Jakob Josiassen1, Jacob E Møller1,2, Lene Holmvang1,3
1Department of Cardiology, Copenhagen University Hospital, Rigshospitalet.
Insights
Acute revascularization is key for myocardial infarction-related cardiogenic shock survival. A culprit-only strategy is best for multivessel disease, and rapid treatment significantly improves outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Critical Care Medicine
Background:
- Myocardial infarction-related cardiogenic shock (MICS) has a high mortality rate.
- Acute revascularization is the primary intervention to improve MICS prognosis.
- Ongoing research explores novel interventions to enhance patient survival.
Purpose of the Study:
- To review interventional treatments for cardiogenic shock.
- To discuss management chronologically from symptom onset to post-catheterization.
- To highlight recent findings and their clinical implications.
Main Methods:
- Review of current literature and clinical trials.
- Analysis of interventional strategies in cardiogenic shock.
- Chronological discussion of treatment pathways.
Main Results:
- Culprit-only revascularization is superior to complete revascularization in multivessel disease (CULPRIT-SHOCK trial).
- Time to revascularization is a critical prognostic factor.
- Transradial access and early mechanical circulatory support show potential benefits, requiring further validation.
Conclusions:
- Acute revascularization is essential for MICS management.
- A culprit-only revascularization strategy should be standard for multivessel disease.
- Optimizing prehospital care and triaging are crucial for improving prognosis in AMI-related cardiogenic shock.
Purpose Of Review:
Acute revascularization is with some evidence the only intervention proven to improve the prognosis in myocardial infarction-related cardiogenic shock but several interventions are continuously being investigated in order to increase survival among these patients. In this review, several aspects related to the interventional treatment of cardiogenic shock are discussed chronologically from symptom debut to leaving the cardiac catheterization laboratory.
Recent Findings:
In the randomized CULPRIT-SHOCK trial, a culprit-only revascularization strategy was reported superior to immediate complete revascularization among patients with multivessel disease. Recent large-scale observational data underline the marked prognostic importance of time from medical contact to revascularization in acute myocardial infarction-related cardiogenic shock. Moreover, studies suggest a potential beneficial effect of a transradial vascular access as well as early initialization of mechanical circulatory support in carefully selected patients. This, however, needs further validation.
Summary:
Acute revascularization remains a crucial part of the initial management of acute myocardial infarction-related cardiogenic shock. Among cardiogenic shock patients presenting with multivessel disease, a culprit-only approach should be the routine strategy. Time to revascularization plays a crucial role in the setting of cardiogenic shock, why prehospital optimization and triaging may be the most important factors in order to improve prognosis in AMI-related cardiogenic shock.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Introduction Cardiac Emergencies
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Coronary Artery Disease V: Interprofessional Care
Myocarditis III: Medical Management

